Objective: The aim of this study was to investigate the association between anti-hypertensive
drugs, the risk of developing an abdominal aortic aneurysm (AAA), aortic wall stiffness …

OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Background The prevalence of abdominal aortic aneurysm (AAA) in a community-based
sample of men and women aged 65–79 years was correlated with known risk factors. In …

Objective—The pathogenesis of abdominal aortic aneurysm (AAA) formation is poorly
understood. We investigated the relationship between carotid, femoral, and coronary …

An abdominal aortic aneurysm (AAA) is defined as a localized dilation of the artery that is 1.5
times the diameter of the normal segment. The most common location for an aortic aneurysm …

INTRODUCTION: Antiplatelet agents, 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors (statin drugs), angiotensin converting enzyme (ACE) inhibitors, and β-adrenergic …

Wedetermined the incidence of coronary lesions bycoronary angiography and the
associated risk factors in 102patients with abdominal aortic aneurysms (AAA) …

Background No effective treatment is currently available to prevent progression of small and
medium-sized abdominal aortic aneurysms (AAAs). Identification of drugs with sufficient …

BACKGROUND: The biomechanical properties of the abdominal aortic aneurysm (AAA) wall
may hold predictive potential. This study aims to study the potential role of wall calcification …

BACKGROUND: A modest (41%) reduction in abdominal aortic aneurysm (AAA) growth rate
is likely to delay AAA-related events (surgery or rupture) by 5 years, making the notion of …